Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?

Int J Cardiol. 2014 Mar 1;172(1):253-4. doi: 10.1016/j.ijcard.2013.12.278. Epub 2014 Jan 10.
No abstract available

Keywords: Ejection fraction; Implantable cardioverter defibrillator; Survival.

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable*
  • Female
  • Heart Failure, Systolic / mortality
  • Heart Failure, Systolic / physiopathology*
  • Heart Failure, Systolic / therapy*
  • Humans
  • Male
  • Middle Aged
  • Primary Prevention
  • Randomized Controlled Trials as Topic
  • Stroke Volume / physiology*
  • Treatment Outcome